• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Bruush Oral Care Inc.

    6/20/24 9:00:44 PM ET
    $BRSH
    Medical/Dental Instruments
    Health Care
    Get the next $BRSH alert in real time by email
    6-K 1 form6-k.htm

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 6-K

     

    Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934

     

    For the month of June 2024
       
    Commission File Number 001-41460

     

    Bruush Oral Care Inc.

    (Translation of registrant’s name into English)

     

    128 West Hastings Street, Unit 210

    Vancouver, British Columbia V6B 1G8

    Canada

    (844) 427-8774

    (Address of principal executive offices)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

     

    Form 20-F ☒ Form 40-F ☐

     

    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

     

    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

     

     

     

     
     

     

    INFORMATION CONTAINED IN THIS FORM 6-K REPORT

     

    On June 13, 2024, Aneil Manhas notified the board of directors of Bruush Oral Care Inc. (the “Company”) of his decision to resign from his positions as the Company’s Chief Executive Officer, director, and Chairman of the board of directors, effective immediately, and the board of directors has accepted such resignation.

     

     
     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

          Bruush Oral Care Inc.
          (Registrant)
             
    Date: June 20, 2024   By: /s/ Mandeek Manhas
          Name: Mandeek Manhas
          Title: Chief Financial Officer

     

     

    Get the next $BRSH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BRSH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BRSH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Brüush Receives Additional Delisting Notification to Address at Hearing

      VANCOUVER, BC / ACCESSWIRE / April 19, 2024 / Bruush Oral Care Inc. (NASDAQ:BRSH) (the "Company"), today announced that it received a notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market, LLC ("Nasdaq") on April 15, 2024 notifying the Company that because it is not compliant with Nasdaq's audit committee requirements as set forth in Listing Rule 5605 (the "Audit Committee Requirements"), this deficiency serves as an additional basis for delisting the Company's securities from Nasdaq. This deficiency will be considered by the Hearings Panel (the "Panel") at a hearing that has been scheduled for April 25, 2024 (the "Hearing") to address the Company's othe

      4/19/24 2:45:00 AM ET
      $BRSH
      Medical/Dental Instruments
      Health Care
    • Brüush Receives Additional Delisting Notification to Address at Hearing

      VANCOUVER, BC / ACCESSWIRE / March 25, 2024 / Bruush Oral Care Inc. (NASDAQ:BRSH) (the "Company"), today announced that it has received a notice from the Listing Qualifications Department of The Nasdaq Stock Market, LLC ("Nasdaq") on March 20, 2024 notifying the Company that because the Company is delinquent in filing its annual report on Form 20-F for the year ended October 31, 2023, this deficiency serves as an additional basis for delisting the Company's securities from Nasdaq per Listing Rule 5810(d). This deficiency will be considered by the Hearings Panel (the "Panel") at a hearing that has been scheduled for April 25, 2024 to address the Company's other current deficiencies.As previou

      3/25/24 6:00:00 PM ET
      $BRSH
      Medical/Dental Instruments
      Health Care
    • Brüush Receives Nasdaq Delisting Notification and Files to Appeal

      VANCOUVER, BC / ACCESSWIRE / March 1, 2024 / Bruush Oral Care Inc. (NASDAQ:BRSH) (the "Company"), today announced that it has received a notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market, LLC ("Nasdaq") on February 27, 2024 notifying the Company of Nasdaq's determination to delist the Company's common shares from The Nasdaq Capital Market because the Company's common shares had a closing bid price of $0.10 or less for ten consecutive trading days as of February 26, 2024, which triggered a notice of delisting pursuant to Nasdaq Listing Rule 5810(c)(3)(A)(iii) (the "Low Priced Stocks Rule").In addition to the Low Priced Stocks Rule delisting notice, as

      3/1/24 11:20:00 PM ET
      $BRSH
      Medical/Dental Instruments
      Health Care